TY - JOUR AU - Evans, D. R. AU - Guy, H. I. PY - 2004 DA - 2004// TI - Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway JO - J Biol Chem VL - 279 ID - Evans2004 ER - TY - JOUR AU - Jones, M. E. PY - 1980 DA - 1980// TI - Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis JO - Annu Rev Biochem VL - 49 ID - Jones1980 ER - TY - JOUR AU - Traut, T. W. PY - 1994 DA - 1994// TI - Physiological concentrations of purines and pyrimidines JO - Mol Cell Biochem VL - 140 ID - Traut1994 ER - TY - JOUR AU - Loffler, M. AU - Fairbanks, L. D. AU - Zameitat, E. AU - Marinaki, A. M. AU - Simmonds, H. A. PY - 2005 DA - 2005// TI - Pyrimidine pathways in health and disease JO - Trends Mol Med VL - 11 ID - Loffler2005 ER - TY - JOUR AU - Jacobson, K. AU - Costanzi, S. AU - Ohno, M. AU - Joshi, B. AU - Besada, P. AU - Xu, B. PY - 2004 DA - 2004// TI - Molecular recognition at purine and pyrimidine nucleotide (P2) receptors JO - Curr Top Med Chem VL - 4 ID - Jacobson2004 ER - TY - JOUR AU - Communi, D. AU - Boeynaems, J. -. M. PY - 1997 DA - 1997// TI - Receptors responsive to extracellular pyrimidine nucleotides JO - Trends Pharmacol Sci VL - 18 ID - Communi1997 ER - TY - JOUR AU - Seifert, R. PY - 2015 DA - 2015// TI - cCMP and cUMP: emerging second messengers JO - Trends Biochem Sci VL - 40 ID - Seifert2015 ER - TY - JOUR AU - Wolter, S. AU - Golombek, M. AU - Seifert, R. PY - 2011 DA - 2011// TI - Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides JO - Biochem Biophys Res Commun VL - 415 ID - Wolter2011 ER - TY - JOUR AU - Levine, R. L. AU - Hoogenraad, N. J. AU - Kretchmer, N. PY - 1974 DA - 1974// TI - A review: biological and clinical aspects of pyrimidine metabolism JO - Pediatr Res VL - 8 ID - Levine1974 ER - TY - JOUR AU - Ito, K. AU - Uchino, H. PY - 1971 DA - 1971// TI - Control of pyrimidine biosynthesis in human lymphocytes. Induction of glutamine-utilizing carbamyl phosphate synthetase and operation of orotic acid pathway during blastogenesis JO - J Biol Chem VL - 246 ID - Ito1971 ER - TY - JOUR AU - Roux, J. M. AU - Hoogenraad, N. J. AU - Kretchmer, N. PY - 1973 DA - 1973// TI - Biosynthesis of pyrimidine nucleotides in mouse salivary glands stimulated with isoproterenol JO - J Biol Chem VL - 248 ID - Roux1973 ER - TY - JOUR AU - Clark, M. L. AU - Senior, J. R. PY - 1969 DA - 1969// TI - Small gut mucosal activities of pyrimidine precursor enzymes in celiac disease JO - Gastroenterology. VL - 56 ID - Clark1969 ER - TY - JOUR AU - Galofré, A. AU - Kretchmer, N. PY - 1970 DA - 1970// TI - Biosynthesis of pyrimidines by various organs of the chick during embryogenesis JO - Pediatr Res VL - 4 ID - Galofré1970 ER - TY - JOUR AU - Young, J. E. AU - Prager, M. D. AU - Atkins, I. C. PY - 1967 DA - 1967// TI - Comparative activties of aspartate transcarbamylase in various tissues of the rat JO - Proc Soc Exp Biol Med VL - 125 ID - Young1967 ER - TY - JOUR AU - Berg, A. A. AU - Lenthe, H. AU - Busch, S. AU - Korte, D. AU - Roos, D. PY - 1993 DA - 1993// TI - Kuilenburg ABP, et al JO - Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia VL - 216 ID - Berg1993 ER - TY - JOUR AU - Volm, M. AU - Zintl, F. AU - Sauerbrey, A. PY - 1994 DA - 1994// TI - Thymidylate synthase in childhood acute non-lymphoblastic leukemia JO - Anticancer Res VL - 14 ID - Volm1994 ER - TY - JOUR AU - Collart, F. R. AU - Chubb, C. B. AU - Mirkin, B. L. AU - Huberman, E. PY - 1992 DA - 1992// TI - Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines JO - Cancer Res VL - 52 ID - Collart1992 ER - TY - JOUR AU - Weber, G. PY - 1983 DA - 1983// TI - Enzymes of purine metabolism in cancer JO - Clin Biochem VL - 16 ID - Weber1983 ER - TY - JOUR AU - Calva, E. AU - Lowenstein, J. M. AU - Cohen, P. P. PY - 1959 DA - 1959// TI - Carbamyl phosphate-aspartate transcarbamylase activity in tumors JO - Cancer Res VL - 19 ID - Calva1959 ER - TY - JOUR AU - Bresnick, E. AU - Mainigi, K. D. AU - Mayfield, E. D. AU - Morris, H. P. PY - 1969 DA - 1969// TI - Activities of enzymes of pyrimidine nucleotide synthesis in slowly growing kidney tumors JO - Cancer Res VL - 29 ID - Bresnick1969 ER - TY - JOUR AU - Urba, S. AU - Doroshow, J. AU - Cripps, C. AU - Robert, F. AU - Velez-Garcia, E. AU - Dallaire, B. PY - 1992 DA - 1992// TI - Multicenter phase II trial of brequinar sodium in patients with advanced squamous-cell carcinoma of the head and neck JO - Cancer Chemother Pharmacol VL - 31 ID - Urba1992 ER - TY - JOUR AU - Natale, R. AU - Wheeler, R. AU - Moore, M. AU - Dallaire, B. AU - Lynch, W. AU - Carlson, R. PY - 1992 DA - 1992// TI - Multicenter phase II trial of brequinar sodium in patients with advanced melanoma JO - Ann Oncol VL - 3 ID - Natale1992 ER - TY - JOUR AU - Moore, M. AU - Maroun, J. AU - Robert, F. AU - Natale, R. AU - Neidhart, J. AU - Dallaire, B. PY - 1993 DA - 1993// TI - Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer JO - Invest New Drugs VL - 11 ID - Moore1993 ER - TY - JOUR AU - Maroun, J. AU - Ruckdeschel, J. AU - Natale, R. AU - Morgan, R. AU - Dallaire, B. AU - Sisk, R. PY - 1993 DA - 1993// TI - Multicenter phase II study of brequinar sodium in patients with advanced lung cancer JO - Cancer Chemother Pharmacol VL - 32 ID - Maroun1993 ER - TY - JOUR AU - Cody, R. AU - Stewart, D. AU - DeForni, M. AU - Moore, M. AU - Dallaire, B. AU - Azarnia, N. PY - 1993 DA - 1993// TI - Multicenter phase II study of brequinar sodium in patients with advanced breast cancer JO - Am J Clin Oncol VL - 16 ID - Cody1993 ER - TY - JOUR AU - Taylor, G. S. AU - Davis, E. T. AU - Falkson, M. G. AU - Keller, M. A. PY - 1982 DA - 1982// TI - PALA in advanced breast cancer. A phase II pilot study by the ECOG JO - Am J Clin Oncol VL - 5 ID - Taylor1982 ER - TY - JOUR AU - Muss, B. H. AU - Bundy, J. B. AU - Disaia, B. P. AU - Stehman, B. F. AU - Beecham, B. J. PY - 1984 DA - 1984// TI - PALA (NSC-224131) in advanced carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group JO - Am J Clin Oncol VL - 7 ID - Muss1984 ER - TY - JOUR AU - Carroll, D. S. AU - Gralla, R. J. AU - Kemeny, N. E. PY - 1980 DA - 1980// TI - Phase II evaluation of N-phosphonacetyl-L-aspartic acid (PALA) in patients with advanced colorectal carcinoma JO - Cancer Treat Rep VL - 64 ID - Carroll1980 ER - TY - JOUR AU - Muggia, F. M. AU - Tsiatis, A. A. AU - O'Connell, M. J. AU - Glick, J. H. AU - Opfell, R. W. AU - Coren, A. PY - 1984 DA - 1984// TI - Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study JO - Cancer Treat Rep VL - 68 ID - Muggia1984 ER - TY - JOUR AU - Kleeberg, U. R. AU - Mulder, J. H. AU - Rümke, P. AU - Thomas, D. AU - Rozencweig, M. PY - 1982 DA - 1982// TI - N-(Phosphonacetyl)- l-aspartate (PALA) in advanced malignant melanoma: a phase II trial of the EORTC malignant melanoma cooperative group JO - Eur J Cancer Clin Oncol VL - 18 ID - Kleeberg1982 ER - TY - JOUR AU - Kurzrock, S. R. AU - Yap, P. B. -. S. AU - Plager, P. C. AU - Papdopoulos, P. N. AU - Benjamin, P. R. AU - Valdivieso, P. M. PY - 1984 DA - 1984// TI - Phase II evaluation of PALA in patients with refractory metastatic sarcomas JO - Am J Clin Oncol VL - 7 ID - Kurzrock1984 ER - TY - JOUR AU - Sykes, D. B. AU - Kfoury, Y. S. AU - Mercier, F. E. AU - Wawer, M. J. AU - Law, J. M. AU - Haynes, M. K. PY - 2016 DA - 2016// TI - Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia JO - Cell VL - 167 ID - Sykes2016 ER - TY - JOUR AU - Ladds, M. AU - Leeuwen, I. M. M. AU - Drummond, C. J. AU - Chu, S. AU - Healy, A. R. AU - Popova, G. PY - 2018 DA - 2018// TI - A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage JO - Nat Commun VL - 9 ID - Ladds2018 ER - TY - JOUR AU - Lewis, T. A. AU - Sykes, D. B. AU - Law, J. M. AU - Muñoz, B. AU - Rustiguel, J. K. AU - Nonato, M. C. PY - 2016 DA - 2016// TI - Development of ML390: a human DHODH inhibitor that induces differentiation in acute myeloid leukemia JO - ACS Med Chem Lett VL - 7 ID - Lewis2016 ER - TY - JOUR AU - DeBerardinis, R. J. AU - Cheng, T. PY - 2009 DA - 2009// TI - Q’s next: the diverse functions of glutamine in metabolism, cell biology and cancer JO - Oncogene. VL - 29 ID - DeBerardinis2009 ER - TY - JOUR AU - Connolly, G. P. AU - Duley, J. A. PY - 1999 DA - 1999// TI - Uridine and its nucleotides: biological actions, therapeutic potentials JO - Trends Pharmacol Sci VL - 20 ID - Connolly1999 ER - TY - JOUR AU - Huang, M. AU - Graves, L. M. PY - 2003 DA - 2003// TI - De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways JO - Cell Mol Life Sci VL - 60 ID - Huang2003 ER - TY - STD TI - Vance JE, Vance DE. Phospholipid biosynthesis in mammalian cells. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2004;82(1):113–28. ID - ref38 ER - TY - STD TI - Friedberg EC, Walkker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. DNA Repair and Mutagenesis. 2nd ed. Washington DC: ASM Press; 2006. ID - ref39 ER - TY - JOUR AU - Tomasetti, C. AU - Li, L. AU - Vogelstein, B. PY - 2017 DA - 2017// TI - Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention JO - Sci VL - 355 ID - Tomasetti2017 ER - TY - JOUR AU - Becroft, D. M. AU - Phillips, L. I. AU - Simmonds, A. PY - 1969 DA - 1969// TI - Hereditary orotic aciduria: long-term therapy with uridine and a trial of uracil JO - J Pediatr VL - 75 ID - Becroft1969 ER - TY - JOUR AU - Tavazzi, B. AU - Lazzarino, G. AU - Leone, P. AU - Amorini, A. M. AU - Bellia, F. AU - Janson, C. G. PY - 2005 DA - 2005// TI - Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism JO - Clin Biochem VL - 38 ID - Tavazzi2005 ER - TY - JOUR AU - Young, J. D. AU - Yao, S. Y. AU - Baldwin, J. M. AU - Cass, C. E. AU - Baldwin, S. A. PY - 2013 DA - 2013// TI - The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29 JO - Mol Aspects Med VL - 34 ID - Young2013 ER - TY - JOUR AU - Young, J. D. AU - Yao, S. Y. AU - Sun, L. AU - Cass, C. E. AU - Baldwin, S. A. PY - 2008 DA - 2008// TI - Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins JO - Xenobiotica; the fate of foreign compounds in biological systems VL - 38 ID - Young2008 ER - TY - JOUR AU - Pastor-Anglada, M. AU - Pérez-Torras, S. PY - 2015 DA - 2015// TI - Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets JO - Front Pharmacol VL - 6 ID - Pastor-Anglada2015 ER - TY - JOUR AU - Damaraju, V. L. AU - Damaraju, S. AU - Young, J. D. AU - Baldwin, S. A. AU - Mackey, J. AU - Sawyer, M. B. PY - 2003 DA - 2003// TI - Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy JO - Oncogene. VL - 22 ID - Damaraju2003 ER - TY - JOUR AU - Boswell-Casteel, R. C. AU - Hays, F. A. PY - 2017 DA - 2017// TI - Equilibrative nucleoside transporters—a review JO - Nucleosides Nucleotides Nucleic Acids VL - 36 ID - Boswell-Casteel2017 ER - TY - JOUR AU - Molina-Arcas, M. AU - Casado, F. J. AU - Pastor-Anglada, M. PY - 2009 DA - 2009// TI - Nucleoside transporter proteins JO - Curr Vasc Pharmacol VL - 7 ID - Molina-Arcas2009 ER - TY - JOUR AU - Zhou, M. AU - Xia, L. AU - Engel, K. AU - Wang, J. PY - 2007 DA - 2007// TI - Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family JO - J Biol Chem VL - 282 ID - Zhou2007 ER - TY - JOUR AU - Rodraguez-Mulero, S. AU - Errasti-Murugarren, E. AU - Ballaran, J. AU - Felipe, A. AU - Doucet, A. AU - Casado, F. PY - 2005 DA - 2005// TI - Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes JO - Kidney Int VL - 68 ID - Rodraguez-Mulero2005 ER - TY - JOUR AU - Smith, K. M. AU - Ng, A. M. L. AU - Yao, S. Y. M. AU - Labedz, K. A. AU - Knaus, E. E. AU - Wiebe, L. I. PY - 2004 DA - 2004// TI - Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes JO - J Physiol VL - 558 ID - Smith2004 ER - TY - JOUR AU - Goetz, U. AU - Prada, M. AU - Pletscher, A. PY - 1971 DA - 1971// TI - Adenine-, guanine- and uridine-5′-phosphonucleotides in blood platelets and storage organelles of various species JO - J Pharmacol Exp Ther VL - 178 ID - Goetz1971 ER - TY - JOUR AU - Berman, P. AU - Harley, E. PY - 1984 DA - 1984// TI - Orotate uptake and metabolism by human erythrocytes JO - Adv Exp Med Biol VL - 165 ID - Berman1984 ER - TY - JOUR AU - Deng, Y. AU - Wang, Z. V. AU - Gordillo, R. AU - An, Y. AU - Zhang, C. AU - Liang, Q. PY - 2017 DA - 2017// TI - An adipo-biliary-uridine axis that regulates energy homeostasis JO - Science (New York, NY) VL - 355 ID - Deng2017 ER - TY - JOUR AU - Teruya, T. AU - Chaleckis, R. AU - Takada, J. AU - Yanagida, M. AU - Kondoh, H. PY - 2019 DA - 2019// TI - Diverse metabolic reactions activated during 58-hr fasting are revealed by non-targeted metabolomic analysis of human blood JO - Sci Rep VL - 9 ID - Teruya2019 ER - TY - JOUR AU - Henricks, L. M. AU - Jacobs, B. A. W. AU - Meulendijks, D. AU - Pluim, D. AU - Broek, D. AU - Vries, N. PY - 2018 DA - 2018// TI - Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteers JO - Br J Clin Pharmacol VL - 84 ID - Henricks2018 ER - TY - JOUR AU - Jacobs, B. A. AU - Deenen, M. J. AU - Pluim, D. AU - Hasselt, J. G. AU - Krahenbuhl, M. D. AU - Geel, R. M. PY - 2016 DA - 2016// TI - Pronounced between-subject and circadian variability in thymidylate synthase and dihydropyrimidine dehydrogenase enzyme activity in human volunteers JO - Br J Clin Pharmacol VL - 82 ID - Jacobs2016 ER - TY - JOUR AU - Groeningen, C. J. AU - Peters, G. J. AU - Nadal, J. C. AU - Laurensse, E. AU - Pinedo, H. M. PY - 1991 DA - 1991// TI - Clinical and pharmacologic study of orally administered uridine JO - J Natl Cancer Inst VL - 83 ID - Groeningen1991 ER - TY - JOUR AU - Kelsen, D. P. AU - Martin, D. AU - O'Neil, J. AU - Schwartz, G. AU - Saltz, L. AU - Sung, M. T. PY - 1997 DA - 1997// TI - Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer JO - J Clin Oncol VL - 15 ID - Kelsen1997 ER - TY - JOUR AU - Steculorum, S. M. AU - Paeger, L. AU - Bremser, S. AU - Evers, N. AU - Hinze, Y. AU - Idzko, M. PY - 2015 DA - 2015// TI - Hypothalamic UDP increases in obesity and promotes feeding via P2Y6-dependent activation of AgRP neurons JO - Cell. VL - 162 ID - Steculorum2015 ER - TY - JOUR AU - Sugiyama, E. AU - Kaniwa, N. AU - Kim, S. -. R. AU - Kikura-Hanajiri, R. AU - Hasegawa, R. AU - Maekawa, K. PY - 2006 DA - 2006// TI - Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism JO - J Clin Oncol VL - 25 ID - Sugiyama2006 ER - TY - JOUR AU - Lamba, J. K. PY - 2009 DA - 2009// TI - Genetic factors influencing cytarabine therapy JO - Pharmacogenomics. VL - 10 ID - Lamba2009 ER - TY - JOUR AU - Deenen, M. J. AU - Meulendijks, D. AU - Cats, A. AU - Sechterberger, M. K. AU - Severens, J. L. AU - Boot, H. PY - 2015 DA - 2015// TI - Upfront genotyping of DPYD*2A to individualize fluoropyrimidine therapy: a safety and cost analysis JO - J Clin Oncol VL - 34 ID - Deenen2015 ER - TY - JOUR AU - Lane, A. N. AU - Fan, T. W. M. PY - 2015 DA - 2015// TI - Regulation of mammalian nucleotide metabolism and biosynthesis JO - Nucleic Acids Res VL - 43 ID - Lane2015 ER - TY - JOUR AU - Miltenberger, R. J. AU - Sukow, K. A. AU - Farnham, P. J. PY - 1995 DA - 1995// TI - An E-box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants JO - Mol Cell Biol VL - 15 ID - Miltenberger1995 ER - TY - JOUR AU - Boyd, K. E. AU - Farnham, P. J. PY - 1997 DA - 1997// TI - Myc versus USF: discrimination at the cad gene is determined by core promoter elements JO - Mol Cell Biol VL - 17 ID - Boyd1997 ER - TY - JOUR AU - Liu, Y. -. C. AU - Li, F. AU - Handler, J. AU - Huang, C. R. L. AU - Xiang, Y. AU - Neretti, N. PY - 2008 DA - 2008// TI - Global regulation of nucleotide biosynthetic genes by c-Myc JO - PLoS One VL - 3 ID - Liu2008 ER - TY - JOUR AU - Khan, S. AU - Abdelrahim, M. AU - Samudio, I. AU - Safe, S. PY - 2003 DA - 2003// TI - Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells JO - Endocrinology. VL - 144 ID - Khan2003 ER - TY - JOUR AU - Chen, K. -. F. AU - Lai, Y. -. Y. AU - Sun, H. S. AU - Tsai, S. -. J. PY - 2005 DA - 2005// TI - Transcriptional repression of human cad gene by hypoxia inducible factor-1α JO - Nucleic Acids Res VL - 33 ID - Chen2005 ER - TY - JOUR AU - Tatibana, M. AU - Shigesada, K. PY - 1972 DA - 1972// TI - Two carbamyl phosphate synthetases of mammals: specific roles in control of pyrimidine and urea biosynthesis JO - Adv Enzyme Regul VL - 10 ID - Tatibana1972 ER - TY - JOUR AU - Rubio, V. AU - Cervera, J. AU - Lusty, C. J. AU - Bendala, E. AU - Britton, H. G. PY - 1991 DA - 1991// TI - Domain structure of the large subunit of Escherichia coli carbamoyl phosphate synthetase. Location of the binding site for the allosteric inhibitor UMP in the carboxy-terminal domain JO - Biochemistry. VL - 30 ID - Rubio1991 ER - TY - JOUR AU - Jones, M. E. PY - 1971 DA - 1971// TI - Regulation of pyrimidine and arginine biosynthesis in mammals JO - Adv Enzyme Regul VL - 9 ID - Jones1971 ER - TY - JOUR AU - Sigoillot, F. D. AU - Evans, D. R. AU - Guy, H. I. PY - 2002 DA - 2002// TI - Growth-dependent regulation of mammalian pyrimidine biosynthesis by the protein kinase A and MAPK signaling cascades JO - J Biol Chem VL - 277 ID - Sigoillot2002 ER - TY - JOUR AU - Graves, L. M. AU - Guy, H. I. AU - Kozlowski, P. AU - Huang, M. AU - Lazarowski, E. AU - Pope, R. M. PY - 2000 DA - 2000// TI - Regulation of carbamoyl phosphate synthetase by MAP kinase JO - Nature. VL - 403 ID - Graves2000 ER - TY - JOUR AU - Kotsis, D. H. AU - Masko, E. M. AU - Sigoillot, F. D. AU - Gregorio, R. D. AU - Guy-Evans, H. I. AU - Evans, D. R. PY - 2007 DA - 2007// TI - Protein kinase A phosphorylation of the multifunctional protein CAD antagonizes activation by the MAP kinase cascade JO - Mol Cell Biochem VL - 301 ID - Kotsis2007 ER - TY - JOUR AU - Carrey, E. A. AU - Campbell, D. G. AU - Hardie, D. G. PY - 1985 DA - 1985// TI - Phosphorylation and activation of hamster carbamyl phosphate synthetase II by cAMP-dependent protein kinase. A novel mechanism for regulation of pyrimidine nucleotide biosynthesis JO - EMBO J VL - 4 ID - Carrey1985 ER - TY - JOUR AU - Sigoillot, F. D. AU - Berkowski, J. A. AU - Sigoillot, S. M. AU - Kotsis, D. H. AU - Guy, H. I. PY - 2003 DA - 2003// TI - Cell cycle-dependent regulation of pyrimidine biosynthesis JO - J Biol Chem VL - 278 ID - Sigoillot2003 ER - TY - JOUR AU - Sigoillot, F. D. AU - Kotsis, D. H. AU - Masko, E. M. AU - Bame, M. AU - Evans, D. R. AU - Evans, H. I. PY - 2007 DA - 2007// TI - Protein kinase C modulates the up-regulation of the pyrimidine biosynthetic complex, CAD, by MAP kinase JO - Front Biosci VL - 12 ID - Sigoillot2007 ER - TY - JOUR AU - Sigoillot, F. D. AU - Sigoillot, S. M. AU - Guy, H. I. PY - 2004 DA - 2004// TI - Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells JO - Int J Cancer VL - 109 ID - Sigoillot2004 ER - TY - JOUR AU - Little Annette, S. AU - Balmanno, K. AU - Sale Matthew, J. AU - Smith Paul, D. AU - Cook, S. J. PY - 2012 DA - 2012// TI - Tumour cell responses to MEK1/2 inhibitors: acquired resistance and pathway remodelling JO - Biochem Soc Trans VL - 40 ID - Little Annette2012 ER - TY - JOUR AU - Wagle, N. AU - Emery, C. AU - Berger, M. F. AU - Davis, M. J. AU - Sawyer, A. AU - Pochanard, P. PY - 2011 DA - 2011// TI - Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling JO - J Clin Oncol VL - 29 ID - Wagle2011 ER - TY - JOUR AU - Liu, F. AU - Yang, X. AU - Geng, M. AU - Huang, M. PY - 2018 DA - 2018// TI - Targeting ERK, an Achilles’ Heel of the MAPK pathway, in cancer therapy JO - Acta pharmaceutica Sinica B VL - 8 ID - Liu2018 ER - TY - JOUR AU - Jha, S. AU - Morris, E. J. AU - Hruza, A. AU - Mansueto, M. S. AU - Schroeder, G. K. AU - Arbanas, J. PY - 2016 DA - 2016// TI - Dissecting therapeutic resistance to ERK inhibition JO - Mol Cancer Ther VL - 15 ID - Jha2016 ER - TY - JOUR AU - Robitaille, A. M. AU - Christen, S. AU - Shimobayashi, M. AU - Cornu, M. AU - Fava, L. L. AU - Moes, S. PY - 2013 DA - 2013// TI - Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis JO - Science (New York, NY) VL - 339 ID - Robitaille2013 ER - TY - JOUR AU - Ben-Sahra, I. AU - Howell, J. J. AU - Asara, J. M. AU - Manning, B. D. PY - 2013 DA - 2013// TI - Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1 JO - Science (New York, NY) VL - 339 ID - Ben-Sahra2013 ER - TY - JOUR AU - Faes, S. AU - Demartines, N. AU - Dormond, O. PY - 2017 DA - 2017// TI - Resistance to mTORC1 inhibitors in cancer therapy: from kinase mutations to intratumoral heterogeneity of kinase activity JO - Oxid Med Cell Longev VL - 2017 ID - Faes2017 ER - TY - JOUR AU - Shimobayashi, M. AU - Hall, M. N. PY - 2014 DA - 2014// TI - Making new contacts: the mTOR network in metabolism and signalling crosstalk JO - Nat Rev Mol Cell Biol VL - 15 ID - Shimobayashi2014 ER - TY - JOUR AU - Ben-Sahra, I. AU - Manning, B. D. PY - 2017 DA - 2017// TI - mTORC1 signaling and the metabolic control of cell growth JO - Curr Opin Cell Biol VL - 45 ID - Ben-Sahra2017 ER - TY - JOUR AU - Sato, T. AU - Akasu, H. AU - Shimono, W. AU - Matsu, C. AU - Fujiwara, Y. AU - Shibagaki, Y. PY - 2015 DA - 2015// TI - Rheb protein binds CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, and dihydroorotase) protein in a GTP- and effector domain-dependent manner and influences its cellular localization and carbamoyl-phosphate synthetase (CPSase) activity JO - J Biol Chem VL - 290 ID - Sato2015 ER - TY - JOUR AU - Ilagan, E. AU - Manning, B. D. PY - 2016 DA - 2016// TI - Emerging role of mTOR in the response to cancer therapeutics JO - Trends in Cancer VL - 2 ID - Ilagan2016 ER - TY - JOUR AU - Inoki, K. AU - Corradetti, M. N. AU - Guan, K. -. L. PY - 2004 DA - 2004// TI - Dysregulation of the TSC-mTOR pathway in human disease JO - Nat Genet VL - 37 ID - Inoki2004 ER - TY - JOUR AU - Menon, S. AU - Manning, B. D. PY - 2009 DA - 2009// TI - Common corruption of the mTOR signaling network in human tumors JO - Oncogene. VL - 27 ID - Menon2009 ER - TY - JOUR AU - Pallet, N. AU - Legendre, C. PY - 2013 DA - 2013// TI - Adverse events associated with mTOR inhibitors JO - Expert Opin Drug Saf VL - 12 ID - Pallet2013 ER - TY - JOUR AU - Linke, S. P. AU - Clarkin, K. C. AU - Leonardo, A. AU - Tsou, A. AU - Wahl, G. M. PY - 1996 DA - 1996// TI - A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage JO - Genes Dev VL - 10 ID - Linke1996 ER - TY - JOUR AU - Haghikia, A. AU - Gold, R. PY - 2014 DA - 2014// TI - TOWER confirms the efficacy of oral teriflunomide in MS JO - Nat Rev Neurol VL - 10 ID - Haghikia2014 ER - TY - JOUR AU - Kasarełło, K. AU - Cudnoch-Jędrzejewska, A. AU - Członkowski, A. AU - Mirowska-Guzel, D. PY - 2017 DA - 2017// TI - Mechanism of action of three newly registered drugs for multiple sclerosis treatment JO - Pharmacol Rep VL - 69 ID - Kasarełło2017 ER - TY - STD TI - Christian S, Merz C, Evans L, Gradl S, Seidel H, Friberg A, et al. The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia. 2019; 33(10):2403–15. ID - ref97 ER - TY - JOUR AU - Grem, J. L. AU - King, S. A. AU - O'Dwyer, P. J. AU - Leyland-Jones, B. PY - 1988 DA - 1988// TI - Biochemistry and clinical activity of N-(phosphonacetyl)-L-aspartate: a review JO - Cancer Res VL - 48 ID - Grem1988 ER - TY - JOUR AU - Hastak, K. AU - Paul, R. K. AU - Agarwal, M. K. AU - Thakur, V. S. AU - Amin, A. R. AU - Agrawal, S. PY - 2008 DA - 2008// TI - DNA synthesis from unbalanced nucleotide pools causes limited DNA damage that triggers ATR-CHK1-dependent p53 activation JO - Proc Natl Acad Sci U S A VL - 105 ID - Hastak2008 ER - TY - JOUR AU - Winum, J. Y. AU - Innocenti, A. AU - Gagnard, V. AU - Montero, J. L. AU - Scozzafava, A. AU - Vullo, D. PY - 2005 DA - 2005// TI - Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates JO - Bioorg Med Chem Lett VL - 15 ID - Winum2005 ER - TY - JOUR AU - Coudray, L. AU - Pennebaker, A. F. AU - Montchamp, J. L. PY - 2009 DA - 2009// TI - Synthesis and in vitro evaluation of aspartate transcarbamoylase inhibitors JO - Bioorg Med Chem VL - 17 ID - Coudray2009 ER - TY - JOUR AU - Kim, J. -. S. AU - Heath, T. D. PY - 2000 DA - 2000// TI - Antitumor efficacy of liposomal N-(phosphonacetyl)-L-aspartic acid in C-26 tumor bearing Balb/c mice JO - J Pharm Investig VL - 30 ID - Kim2000 ER - TY - JOUR AU - Kim, J. -. S. AU - Heath, T. D. PY - 2000 DA - 2000// TI - Therapeutic potency of N-(Phosphonacetyl)-L-Aspartic Acid in liposome in established tumor bearing mice JO - J Pharm Investig VL - 30 ID - Kim2000 ER - TY - JOUR AU - Ng, S. B. AU - Buckingham, K. J. AU - Lee, C. AU - Bigham, A. W. AU - Tabor, H. K. AU - Dent, K. M. PY - 2010 DA - 2010// TI - Exome sequencing identifies the cause of a mendelian disorder JO - Nat Genet VL - 42 ID - Ng2010 ER - TY - JOUR AU - Dexter, D. L. AU - Hesson, D. P. AU - Ardecky, R. J. AU - Rao, G. V. AU - Tippett, D. L. AU - Dusak, B. A. PY - 1985 DA - 1985// TI - Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors JO - Cancer Res VL - 45 ID - Dexter1985 ER - TY - JOUR AU - Brown, K. K. AU - Spinelli, J. B. AU - Asara, J. M. AU - Toker, A. PY - 2017 DA - 2017// TI - Adaptive reprogramming of de novo pyrimidine synthesis is a metabolic vulnerability in triple-negative breast cancer JO - Cancer Discov VL - 7 ID - Brown2017 ER - TY - JOUR AU - Mathur, D. AU - Stratikopoulos, E. AU - Ozturk, S. AU - Steinbach, N. AU - Pegno, S. AU - Schoenfeld, S. PY - 2017 DA - 2017// TI - PTEN regulates glutamine flux to pyrimidine synthesis and sensitivity to dihydroorotate dehydrogenase inhibition JO - Cancer Discov VL - 7 ID - Mathur2017 ER - TY - JOUR AU - White, R. M. AU - Cech, J. AU - Ratanasirintrawoot, S. AU - Lin, C. Y. AU - Rahl, P. B. AU - Burke, C. J. PY - 2011 DA - 2011// TI - DHODH modulates transcriptional elongation in the neural crest and melanoma JO - Nature. VL - 471 ID - White2011 ER - TY - JOUR AU - Koundinya, M. AU - Sudhalter, J. AU - Courjaud, A. AU - Lionne, B. AU - Touyer, G. AU - Bonnet, L. PY - 2018 DA - 2018// TI - Dependence on the pyrimidine biosynthetic enzyme DHODH is a synthetic lethal vulnerability in mutant KRAS-driven cancers JO - Cell chemical biology VL - 25 ID - Koundinya2018 ER - TY - JOUR AU - Santana-Codina, N. AU - Roeth, A. A. AU - Zhang, Y. AU - Yang, A. AU - Mashadova, O. AU - Asara, J. M. PY - 2018 DA - 2018// TI - Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis JO - Nat Commun VL - 9 ID - Santana-Codina2018 ER - TY - JOUR AU - Huang, H. -. S. AU - Wang, R. AU - Chen, W. -. J. AU - Chen, J. -. Z. AU - Gong, S. -. S. AU - Sun, Q. PY - 2018 DA - 2018// TI - The first chemical synthesis of pyrazofurin 5′-triphosphate JO - Tetrahedron Lett VL - 59 ID - Huang2018 ER - TY - JOUR AU - Dix, D. E. AU - Lehman, C. P. AU - Jakubowski, A. AU - Moyer, J. D. AU - Handschumacher, R. E. PY - 1979 DA - 1979// TI - Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells JO - Cancer Res VL - 39 ID - Dix1979 ER - TY - JOUR AU - Ringer, D. P. AU - Howell, B. A. AU - Etheredge, J. L. PY - 1991 DA - 1991// TI - Alteration in de novo pyrimidine biosynthesis during uridine reversal of pyrazofurin-inhibited dna synthesis JO - J Biochem Toxicol VL - 6 ID - Ringer1991 ER - TY - JOUR AU - Bardeleben, C. AU - Sharma, S. AU - Reeve, J. R. AU - Bassilian, S. AU - Frost, P. AU - Hoang, B. PY - 2013 DA - 2013// TI - Metabolomics identifies pyrimidine starvation as the mechanism of 5-aminoimidazole-4-carboxamide-1-β-riboside-induced apoptosis in multiple myeloma cells JO - Mol Cancer Ther VL - 12 ID - Bardeleben2013 ER - TY - JOUR AU - Suchi, M. AU - Mizuno, H. AU - Kawai, Y. AU - Tsuboi, T. AU - Sumi, S. AU - Okajima, K. PY - 1997 DA - 1997// TI - Molecular cloning of the human UMP synthase gene and characterization of point mutations in two hereditary orotic aciduria families JO - Am J Hum Genet VL - 60 ID - Suchi1997 ER - TY - JOUR AU - Cantor, J. R. AU - Abu-Remaileh, M. AU - Kanarek, N. AU - Freinkman, E. AU - Gao, X. AU - Louissaint, A. PY - 2017 DA - 2017// TI - Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase JO - Cell VL - 169 ID - Cantor2017 ER - TY - JOUR AU - Griffiths, M. AU - Beaumont, N. AU - Yao, S. Y. M. AU - Sundaram, M. AU - Boumah, C. E. AU - Davies, A. PY - 1997 DA - 1997// TI - Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs JO - Nat Med VL - 3 ID - Griffiths1997 ER - TY - JOUR AU - Crawford, C. R. AU - Patel, D. H. AU - Naeve, C. AU - Belt, J. A. PY - 1998 DA - 1998// TI - Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line JO - J Biol Chem VL - 273 ID - Crawford1998 ER - TY - JOUR AU - Huang, M. AU - Wang, Y. AU - Cogut, S. B. AU - Mitchell, B. S. AU - Graves, L. M. PY - 2003 DA - 2003// TI - Inhibition of nucleoside transport by protein kinase inhibitors JO - J Pharmacol Exp Ther VL - 304 ID - Huang2003 ER - TY - JOUR AU - Damaraju, V. L. AU - Weber, D. AU - Kuzma, M. AU - Cass, C. E. AU - Sawyer, M. B. PY - 2016 DA - 2016// TI - Selective inhibition of human equilibrative and concentrative nucleoside transporters by bcr-abl kinase Inhibitors: identification of key hent1 amino acid residues for interaction with bcr-abl kinase inhibitors JO - J Biol Chem VL - 291 ID - Damaraju2016 ER - TY - JOUR AU - King, A. E. AU - Ackley, M. A. AU - Cass, C. E. AU - Young, J. D. AU - Baldwin, S. A. PY - 2006 DA - 2006// TI - Nucleoside transporters: from scavengers to novel therapeutic targets JO - Trends Pharmacol Sci VL - 27 ID - King2006 ER - TY - JOUR AU - Zhang, J. AU - Visser, F. AU - King, K. M. AU - Baldwin, S. A. AU - Young, J. D. AU - Cass, C. E. PY - 2007 DA - 2007// TI - The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs JO - Cancer Metastasis Rev VL - 26 ID - Zhang2007 ER - TY - JOUR AU - Damaraju, V. L. AU - Smith, K. M. AU - Mowles, D. AU - Nowak, I. AU - Karpinski, E. AU - Young, J. D. PY - 2011 DA - 2011// TI - Interaction of fused-pyrimidine nucleoside analogs with human concentrative nucleoside transporters: high-affinity inhibitors of human concentrative nucleoside transporter 1 JO - Biochem Pharmacol VL - 81 ID - Damaraju2011 ER - TY - JOUR AU - Chabner, B. A. AU - Johns, D. G. AU - Coleman, C. N. AU - Drake, J. C. AU - Evans, W. H. PY - 1974 DA - 1974// TI - Purification and properties of cytidine deaminase from normal and leukemic granulocytes JO - J Clin Invest VL - 53 ID - Chabner1974 ER - TY - STD TI - Garcia-Manero G, Odenike O, Amrein PC, Steensma DP, DeZern AE, Michaelis LC, et al. Successful emulation of IV decitabine pharmacokinetics with an oral fixed-dose combination of the oral cytidine deaminase inhibitor (CDAi) E7727 with oral decitabine, in subjects with myelodysplastic syndromes (MDS): final data of phase 1 study. Blood. 2016;128(22):114. ID - ref125 ER - TY - JOUR AU - Kizaki, H. AU - Williams, J. C. AU - Morris, H. P. AU - Weber, G. PY - 1980 DA - 1980// TI - Increased cytidine 5′-triphosphate synthetase activity in rat and human tumors JO - Cancer Res VL - 40 ID - Kizaki1980 ER - TY - JOUR AU - Gou, K. M. AU - Chang, C. C. AU - Shen, Q. J. AU - Sung, L. Y. AU - Liu, J. L. PY - 2014 DA - 2014// TI - CTP synthase forms cytoophidia in the cytoplasm and nucleus JO - Exp Cell Res VL - 323 ID - Gou2014 ER - TY - JOUR AU - Lynch, E. M. AU - Hicks, D. R. AU - Shepherd, M. AU - Endrizzi, J. A. AU - Maker, A. AU - Hansen, J. M. PY - 2017 DA - 2017// TI - Human CTP synthase filament structure reveals the active enzyme conformation JO - Nat Struct Mol Biol VL - 24 ID - Lynch2017 ER - TY - JOUR AU - Higgins, M. J. AU - Loiselle, D. AU - Haystead, T. A. AU - Graves, L. M. PY - 2008 DA - 2008// TI - Human cytidine triphosphate synthetase 1 interacting proteins JO - Nucleosides Nucleotides Nucleic Acids VL - 27 ID - Higgins2008 ER - TY - JOUR AU - Calise, S. J. AU - Carcamo, W. C. AU - Krueger, C. AU - Yin, J. D. AU - Purich, D. L. AU - Chan, E. K. PY - 2014 DA - 2014// TI - Glutamine deprivation initiates reversible assembly of mammalian rods and rings JO - Cell Mol life Sci VL - 71 ID - Calise2014 ER - TY - JOUR AU - Zhang, J. AU - Hulme, L. AU - Liu, J. L. PY - 2014 DA - 2014// TI - Asymmetric inheritance of cytoophidia in Schizosaccharomyces pombe JO - Biology open VL - 3 ID - Zhang2014 ER - TY - JOUR AU - Schimmel, K. J. AU - Gelderblom, H. AU - Guchelaar, H. J. PY - 2007 DA - 2007// TI - Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity JO - Curr Cancer Drug Targets VL - 7 ID - Schimmel2007 ER -